Will the Mounjaro weight-loss drug reshape the Indian stock markets? Nithin Kamath says ‘people will trade less’
Mounjaro, a newly launched weight-loss and diabetes drug, is now available in India. Developed by Eli Lilly, it promises more effectiveness than Ozempic and comes at a lower cost. Experts believe it ...
The Financial Express51m
Nithin Kamath calls weight loss drugs ‘closest thing to miracle,’ but warns against hype
A single-dose vial of Mounjaro costs Rs. 3,500 for 2.5 mg or Rs. 4,375 for 5 mg. On a typical weekly dose, that adds up to ...